...
首页> 外文期刊>Hospital pharmacy. >Smoothing the Path for Intravenous (IV)to Oral (PO) Conversion: Where HaveWe Come in 11 Years?
【24h】

Smoothing the Path for Intravenous (IV)to Oral (PO) Conversion: Where HaveWe Come in 11 Years?

机译:为静脉(IV)转换为口服(PO)铺平道路:11年后我们走向何方?

获取原文
获取原文并翻译 | 示例

摘要

Purpose: The objectives of this study were to determine how many hospitals have active programs for converting patients from intravenous (IV) to oral (PO) therapy and obtain details of their conversion policies and documented cost savings and clinical impact from the IV to PO programs. In addition, the perceived benefits of these types of pharmacy programs will be highlighted.Methods: Surveys were sent via e-mail to approximately 7,905 pharmacy managers and clinical pharmacists throughout the United States, which were obtained from American Society of Health-System Pharmacists (ASHP) and American College of Clinical Pharmacy (ACCP) by working through various list-serves that target this group of practitioners. The survey questioned participants regarding their hospital's policies for IV to PO conversion programs, including demographics, criteria, process, medications involved in the switches, clinical outcomes, and cost savings of such programs.Results: Of 276 surveys completed and returned, 42% of responders were from the south; 81% had an active IV to PO program (larger hospital systems were more likely to have a program in existence for a longer period of time); and 82% identified patients via a computer-generated list of target patients and drugs for pharmacists to intervene. The majority of medications involved in IV to PO switches included antibiotics, GI, and antifungal drug classes. Fifty-four percent of responders indicated pharmacy manpower was the largest barrier to implementation and continuation of IV to PO conversion programs. Sixty-seven percent of responders documented cost savings and 47% of the 81 facilities that specified savings had saved at least Dollars 50,000 annually.Conclusion: There was no change in the percent of facilities with IV to PO conversion programs (81%). There were minimal differences in the types of medications involved in conversion programs between 1996 and 2007. The policy and procedures supporting these type of programs have become more defined in the 11 years between surveys. In addition, methods of conversions have become more automatic since the first survey. Financial impact of IV to PO conversion programs were documented in both surveys.
机译:目的:本研究的目的是确定有多少家医院制定了将患者从静脉(IV)转换为口服(PO)治疗的积极计划,并获得其转换政策的详细信息以及从IV到PO计划的成本节约和临床影响的书面记录。此外,还将重点介绍这些类型的药房计划带来的可观收益。方法:通过电子邮件将调查问卷发送给全美国大约7905名药房经理和临床药师,这些药房是从美国卫生系统药剂师协会(American Society of Health-System Pharmacists)获得的( ASHP)和美国临床药学学院(ACCP)通过针对该组从业者的各种列表服务进行工作。调查向参与者询问了他们医院关于IV到PO转换计划的政策,包括人口统计学,标准,过程,转换涉及的药物,临床结局以及此类计划的成本节省结果:在276项已完成并返回的调查中,有42%响应者来自南方; 81%的患者有积极的IV到PO计划(较大的医院系统更有可能在更长的时间内存在该计划);另有82%的人通过计算机生成的目标患者和药师进行干预的药物清单确定了患者。 IV至PO转换涉及的大多数药物包括抗生素,胃肠道和抗真菌药物类别。 54%的响应者表示,药房人力是实施和继续IV到PO转换计划的最大障碍。 67%的响应者记录了成本节省,在81项指定节省的设施中,有47%的设施每年至少节省了50,000美元。结论:IV到PO转换程序的设施百分比没有变化(81%)。在1996年至2007年之间,转化计划所涉及的药物类型之间的差异很小。在两次调查之间的11年中,支持此类计划的政策和程序变得更加明确。此外,自首次调查以来,转换方法已变得更加自动化。两项调查均记录了IV到PO转换计划的财务影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号